| ZD6474 in Treating Patients With Small Cell Lung Cancer (NCT00066313) | Genzyme, a Sanofi Company | 2003-05-01 |
| Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer (NCT00062270) | University of Alabama at Birmingham | 2003-05-01 |
| Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer (NCT00064012) | University of Wisconsin, Madison | 2003-05-01 |
| Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers (NCT00061997) | British Columbia Cancer Agency | 2003-05-01 |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors (NCT00471432) | NCIC Clinical Trials Group | 2003-04-04 |
| Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00049218) | H. Lee Moffitt Cancer Center and Research Institute | 2003-04-01 |
| Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00061854) | Daiichi Sankyo | 2003-04-01 |
| Removal of Lung Nodules After Being Marked With a Microcoil (NCT00323089) | University of British Columbia | 2003-04-01 |
| Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer (NCT00061919) | University College, London | 2003-04-01 |
| High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer (NCT00062335) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-04-01 |
| Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery (NCT00501319) | M.D. Anderson Cancer Center | 2003-04-01 |
| Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC (NCT00226590) | H. Lee Moffitt Cancer Center and Research Institute | 2003-04-01 |
| Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00052494) | University Health Network, Toronto | 2003-04-01 |
| Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins (NCT00131586) | AHS Cancer Control Alberta | 2003-04-01 |
| Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE) (NCT00898209) | Vanderbilt-Ingram Cancer Center | 2003-04-01 |
| Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients (NCT00423436) | M.D. Anderson Cancer Center | 2003-04-01 |
| Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00059761) | Radiation Therapy Oncology Group | 2003-03-01 |
| Alanosine in Treating Patients With Cancer (NCT00062283) | Memorial Sloan Kettering Cancer Center | 2003-03-01 |
| A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) (NCT00089726) | Cell Genesys | 2003-03-01 |
| Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer (NCT00193336) | SCRI Development Innovations, LLC | 2003-03-01 |
| Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer (NCT00059605) | M.D. Anderson Cancer Center | 2003-03-01 |
| Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC (NCT00238615) | Stanford University | 2003-03-01 |
| Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (NCT00062179) | Jonsson Comprehensive Cancer Center | 2003-03-01 |
| DNA Repair and Genetic Susceptibility to Lung Cancer (NCT00611598) | Memorial Sloan Kettering Cancer Center | 2003-02-11 |
| Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors (NCT00054977) | Galectin Therapeutics Inc. | 2003-02-01 |
| Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00062322) | Fox Chase Cancer Center | 2003-02-01 |
| Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00057746) | Radiation Therapy Oncology Group | 2003-02-01 |
| Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer (NCT00078390) | Shionogi | 2003-02-01 |
| Study of Health Effects of Cosmetic Breast Augmentation (NCT00342953) | National Cancer Institute (NCI) | 2003-01-10 |
| Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer (NCT00619021) | Masonic Cancer Center, University of Minnesota | 2003-01-01 |
| S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer (NCT00045617) | SWOG Cancer Research Network | 2003-01-01 |
| Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer (NCT00054184) | CTI BioPharma | 2003-01-01 |
| 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer (NCT00064064) | Vion Pharmaceuticals | 2003-01-01 |
| Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer (NCT00054210) | CTI BioPharma | 2003-01-01 |
| A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer (NCT00144066) | West Japan Thoracic Oncology Group | 2003-01-01 |
| Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer (NCT00579462) | Memorial Sloan Kettering Cancer Center | 2003-01-01 |
| Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer (NCT00054197) | CTI BioPharma | 2003-01-01 |
| Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients (NCT00502502) | M.D. Anderson Cancer Center | 2002-11-01 |
| Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin (NCT00055965) | The Christie NHS Foundation Trust | 2002-11-01 |
| S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer (NCT00045162) | SWOG Cancer Research Network | 2002-11-01 |
| Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00055887) | Spectrum Pharmaceuticals, Inc | 2002-11-01 |
| R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer (NCT00005989) | Mayo Clinic | 2002-11-01 |
| Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00075426) | The University of Texas Medical Branch, Galveston | 2002-11-01 |
| Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00041314) | Eastern Cooperative Oncology Group | 2002-10-04 |
| Celecoxib in Preventing Lung Cancer in Former Heavy Smokers (NCT00055978) | University of California, Los Angeles | 2002-10-01 |
| Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy (NCT00052325) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2002-10-01 |
| Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide (NCT00290953) | Sanofi | 2002-10-01 |
| Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) (NCT00040885) | Alliance for Clinical Trials in Oncology | 2002-10-01 |
| Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00058006) | Northwestern University | 2002-09-01 |
| Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer (NCT00059943) | Memorial Sloan Kettering Cancer Center | 2002-09-01 |
| Surveillance For New Lung Primaries (NCT00205413) | University of Wisconsin, Madison | 2002-09-01 |
| Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer (NCT00193388) | SCRI Development Innovations, LLC | 2002-09-01 |
| Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer (NCT00048997) | Radiation Therapy Oncology Group | 2002-09-01 |
| ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia (NCT00522197) | British Columbia Cancer Agency | 2002-09-01 |
| Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer (NCT00193349) | SCRI Development Innovations, LLC | 2002-09-01 |
| A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood (NCT00117442) | Amgen | 2002-08-01 |
| Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00053300) | Case Comprehensive Cancer Center | 2002-08-01 |
| National Lung Screening Trial (NLST) Screening (NCT00047385) | National Cancer Institute (NCI) | 2002-08-01 |
| Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer (NCT00193401) | SCRI Development Innovations, LLC | 2002-08-01 |
| Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer (NCT00043823) | M.D. Anderson Cancer Center | 2002-08-01 |
| Collection of Blood From Patients With Cancer (NCT00034216) | National Cancer Institute (NCI) | 2002-07-16 |
| Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00045604) | Memorial Sloan Kettering Cancer Center | 2002-07-01 |
| Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00043108) | Fox Chase Cancer Center | 2002-07-01 |
| Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00390429) | University of California, Davis | 2002-07-01 |
| Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors (NCT00049608) | National Center for Complementary and Integrative Health (NCCIH) | 2002-07-01 |
| Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer (NCT00046839) | Radiation Therapy Oncology Group | 2002-07-01 |
| Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00416650) | Vanderbilt-Ingram Cancer Center | 2002-07-01 |
| A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer (NCT00277160) | Amgen | 2002-06-01 |
| Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer (NCT00039507) | Fox Chase Cancer Center | 2002-06-01 |
| Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00041054) | Alliance for Clinical Trials in Oncology | 2002-06-01 |
| Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer (NCT00077220) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2002-06-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00032032) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications (NCT00260871) | National Health Research Institutes, Taiwan | 2002-05-01 |
| EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer (NCT00041028) | Duke University | 2002-05-01 |
| Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer (NCT00281827) | Masonic Cancer Center, University of Minnesota | 2002-05-01 |
| Computer-Assisted Counseling in Helping African American Smokers Stop Smoking (NCT00310141) | M.D. Anderson Cancer Center | 2002-04-08 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients (NCT00397124) | Rambam Health Care Campus | 2002-04-01 |
| Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00033410) | California Cancer Consortium | 2002-03-01 |
| Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer (NCT00033553) | Alliance for Clinical Trials in Oncology | 2002-03-01 |
| BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer (NCT00054314) | Roswell Park Cancer Institute | 2002-03-01 |
| Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00033722) | Tularik | 2002-02-01 |
| CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer (NCT00033384) | University of Alabama at Birmingham | 2002-02-01 |
| Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00248482) | Barbara Ann Karmanos Cancer Institute | 2002-02-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking (NCT00033592) | Alliance for Clinical Trials in Oncology | 2002-02-01 |
| Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma (NCT00568906) | Stanford University | 2002-02-01 |
| ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00034346) | Amgen | 2002-01-01 |
| Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer (NCT00028938) | Wake Forest University Health Sciences | 2002-01-01 |
| Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer (NCT00022711) | Fox Chase Cancer Center | 2002-01-01 |
| Radiofrequency Ablation of Lung Tumors (NCT00180856) | Gustave Roussy, Cancer Campus, Grand Paris | 2002-01-01 |
| S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00030433) | SWOG Cancer Research Network | 2002-01-01 |
| TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00036920) | Memorial Sloan Kettering Cancer Center | 2002-01-01 |
| S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery (NCT00032084) | SWOG Cancer Research Network | 2002-01-01 |
| Subcutaneous Amifostine Safety Study (NCT00158041) | Mt. Sinai Medical Center, Miami | 2002-01-01 |
| Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer (NCT00039052) | Neurocrine Biosciences | 2002-01-01 |
| Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer (NCT00139971) | West Japan Thoracic Oncology Group | 2001-12-01 |
| Surveillance For New Lung Primaries (NCT00205439) | University of Wisconsin, Madison | 2001-12-01 |
| Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer (NCT00028925) | Alliance for Clinical Trials in Oncology | 2001-11-01 |
| S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00026156) | SWOG Cancer Research Network | 2001-11-01 |